Description
GLIPVAS 50 TAB is an oral anti-diabetic medication containing Vildagliptin 50 mg, a DPP-4 (dipeptidyl peptidase-4) inhibitor. It is used to manage type 2 diabetes mellitus in adults, either as monotherapy or in combination with other antidiabetic agents like Metformin, Sulfonylureas, or Insulin.
Vildagliptin works by inhibiting the DPP-4 enzyme, which prolongs the activity of incretin hormones (GLP-1 and GIP). These hormones stimulate glucose-dependent insulin release and suppress glucagon secretion, thereby lowering blood glucose levels effectively without causing significant weight gain or hypoglycemia.
Therapeutic Uses:
-
Type 2 diabetes mellitus (T2DM)
-
As monotherapy when Metformin is not suitable
-
In combination with Metformin, Sulfonylureas, or Insulin
-
Effective blood sugar control for diabetic patients with cardiovascular risk
Key Benefits:
-
Improves glycemic control in adults with T2DM
-
Low risk of hypoglycemia
-
Can be used in combination with other antidiabetics
-
Weight-neutral profile
-
Convenient once or twice-daily dosing
GLIPVAS 50 TAB is manufactured in WHO-GMP and ISO-certified facilities and is exported internationally by BLUEPILL EXPRESS, a trusted name in global pharmaceutical supply. BLUEPILL EXPRESS ensures quality manufacturing, regulatory compliance, export certification, and on-time delivery to markets in Asia, Africa, the Middle East, Europe, and Latin America.
